Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04312009 · ClinicalTrials.gov registry record · Phase 2
Losartan for Patients With COVID-19 Requiring Hospitalization
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 205
- Enrollment target
NCT04312009 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 205 participants.
The verdict
NCT04312009, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 205 participants
- Enrollment target
Study Summary
This is a multi-center, double-blinded study of COVID-19 infected patients requiring inpatient hospital admission randomized 1:1 to daily Losartan or placebo for 7 days or hospital discharge.
Interventions
- OTHER Placebo
- DRUG Losartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2020-04-13 |
| Est. Completion | 2021-02-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04312009
The ClinicalTrials.gov registry entry for NCT04312009 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04312009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04312009 about?
NCT04312009 is a clinical study titled "Losartan for Patients With COVID-19 Requiring Hospitalization". This is a multi-center, double-blinded study of COVID-19 infected patients requiring inpatient hospital admission randomized 1:1 to daily Losartan or placebo for 7 days or hospital discharge.
What is the current status of trial NCT04312009?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 205 participants. The study started on 2020-04-13. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT04312009?
The interventions under investigation include: Placebo (OTHER), Losartan (DRUG).
Who is sponsoring clinical trial NCT04312009?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.